Trade Name: Tecentriq™
Atezolizumab is the generic name for the trade drug name Tecentriq™. In some cases, health care professionals may use the generic name atezolizumab when referring to the trade drug name Tecentriq™.

Drug type: Atezolizumab is an Anti-PD-L1 monoclonal antibody. (For more detail, see "How this drug works," below).

What Atezolizumab Is Used For :
For the treatment of patients with locally advanced or metastatic urothelial carcinoma who:
  • Have disease progression during or following platinum-containing chemotherapy.
  • Have disease progression within 12 months of neoadjuvant or adjuvant treatment with platinum-containing chemotherapy.

Note: If a drug has been approved for one use, physicians may elect to use this same drug for other problems if they believe it may be helpful.

How Atezolizumab Is Given :
  • Atezolizumab is given as an intravenous injection through a vein (IV) over 60 minutes for the first infusion, and if no infusion reaction, over 30 minutes for each infusion thereafter.
  • Treatment cycles are every 3 weeks (21 days)
  • You may receive medications before the infusion to reduce allergic reactions.